These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 27339764)

  • 41. Treatment of hyperammonemia in liver failure.
    Jover-Cobos M; Khetan V; Jalan R
    Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):105-10. PubMed ID: 24281376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatic encephalopathy is linked to alterations of autophagic flux in astrocytes.
    Lu K; Zimmermann M; Görg B; Bidmon HJ; Biermann B; Klöcker N; Häussinger D; Reichert AS
    EBioMedicine; 2019 Oct; 48():539-553. PubMed ID: 31648987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug-induced removal of nitrogen derivatives in urine: a new concept whose time has come.
    Córdoba J; Ventura-Cots M
    Hepatology; 2014 Mar; 59(3):764-6. PubMed ID: 24123173
    [No Abstract]   [Full Text] [Related]  

  • 44. Current state of knowledge of hepatic encephalopathy (Part V): clinical efficacy of L-ornithine-L-aspartate in the management of HE.
    Kircheis G
    Metab Brain Dis; 2016 Dec; 31(6):1365-1367. PubMed ID: 27838865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of ammonia and inflammation in minimal hepatic encephalopathy.
    Shawcross DL; Wright G; Olde Damink SW; Jalan R
    Metab Brain Dis; 2007 Mar; 22(1):125-38. PubMed ID: 17260161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid metabolic and bioenergetic adaptations of astrocytes under hyperammonemia - a novel perspective on hepatic encephalopathy.
    Zimmermann M; Reichert AS
    Biol Chem; 2021 Aug; 402(9):1103-1113. PubMed ID: 34331848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multifactorial Effects on Different Types of Brain Cells Contribute to Ammonia Toxicity.
    Hertz L; Song D; Peng L; Chen Y
    Neurochem Res; 2017 Mar; 42(3):721-736. PubMed ID: 27286679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure.
    Ytrebø LM; Kristiansen RG; Maehre H; Fuskevåg OM; Kalstad T; Revhaug A; Cobos MJ; Jalan R; Rose CF
    Hepatology; 2009 Jul; 50(1):165-74. PubMed ID: 19554542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Amino acids prevent hepatic encephalopathy. Ornithine-aspartate in hyperammonemia--results of a study].
    Hartung HD
    Fortschr Med; 1989 Mar; 107(8):56. PubMed ID: 2651255
    [No Abstract]   [Full Text] [Related]  

  • 50. Ammonia toxicity under hyponatremic conditions in astrocytes: de novo synthesis of amino acids for the osmoregulatory response.
    Zwingmann C; Leibfritz D
    Neurochem Int; 2005 Jul; 47(1-2):39-50. PubMed ID: 15908044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis.
    Ott P; Clemmesen O; Larsen FS
    Neurochem Int; 2005 Jul; 47(1-2):13-8. PubMed ID: 15921824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy.
    Cauli O; Rodrigo R; Llansola M; Montoliu C; Monfort P; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
    Metab Brain Dis; 2009 Mar; 24(1):69-80. PubMed ID: 19085094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. α-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycle.
    Cooper AJ; Kuhara T
    Metab Brain Dis; 2014 Dec; 29(4):991-1006. PubMed ID: 24234505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An orally deliverable ornithine-based self-assembling polymer nanomedicine ameliorates hyperammonemia in acetaminophen-induced acute liver injury.
    Ding Y; Koda Y; Shashni B; Takeda N; Zhang X; Tanaka N; Nishikawa Y; Nagasaki Y
    Acta Biomater; 2023 Sep; 168():515-528. PubMed ID: 37433359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment--results of a pilot study.
    Delcker A; Turowski B; Mihm U; Raab P; Rusch O; Pilatus U; Zeuzem S; Zanella FE
    Metab Brain Dis; 2002 Jun; 17(2):103-11. PubMed ID: 12083335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis.
    Zhu R; Liu L; Zhang G; Dong J; Ren Z; Li Z
    Biosci Rep; 2023 Jun; 43(6):. PubMed ID: 37279097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The anaplerotic flux and ammonia detoxification in hepatic encephalopathy.
    Zwingmann C
    Metab Brain Dis; 2007 Dec; 22(3-4):235-49. PubMed ID: 17823857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats.
    Davies NA; Wright G; Ytrebø LM; Stadlbauer V; Fuskevåg OM; Zwingmann C; Davies DC; Habtesion A; Hodges SJ; Jalan R
    Hepatology; 2009 Jul; 50(1):155-64. PubMed ID: 19437490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein tyrosine nitration in hyperammonemia and hepatic encephalopathy.
    Häussinger D; Görg B; Reinehr R; Schliess F
    Metab Brain Dis; 2005 Dec; 20(4):285-94. PubMed ID: 16382339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nuclear magnetic resonance studies of energy metabolism and glutamine shunt in hepatic encephalopathy and hyperammonemia.
    Zwingmann C
    J Neurosci Res; 2007 Nov; 85(15):3429-42. PubMed ID: 17722064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.